Thomas Eiβing

Title: The Innovations of Thomas Eiβing

Introduction

Thomas Eiβing is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in drug formulation. His innovative approach focuses on addressing variability in drug metabolism among individuals.

Latest Patents

Eiβing holds a patent for a groundbreaking invention titled "Genotype- or phenotype-based drug formulation." This invention relates to a combination of two or more pharmaceutically active substances, where at least one is a metabolic product of the other. The dosages are specifically selected to compensate for genotypically or phenotypically related variability in the conversion of the parent substance to the metabolite in individual patients. This patent highlights his commitment to personalized medicine.

Career Highlights

Thomas Eiβing is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer allows him to collaborate with some of the brightest minds in the industry. His innovative spirit and dedication to improving drug formulations have made him a valuable asset to his team.

Collaborations

Eiβing has worked alongside talented colleagues such as Kristin Dickschen and Stefan Willmann. Their collaborative efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Thomas Eiβing's contributions to drug formulation and personalized medicine are noteworthy. His patent reflects a deep understanding of pharmacogenomics and its application in improving patient outcomes. His work at Bayer and collaborations with esteemed colleagues further enhance the impact of his innovations in the pharmaceutical industry.